These data highlight the potential significance of targeting the PI3K/AKT signalling pathways in HNSCC (Van Baal et al, 2006; Bussink et al, 2008; Haddad and Shin, 2008). The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.